NCT02228473

Effect of Glycopyrrolate and Atropine on Catheter-Related Bladder Discomfort

Effect of Glycopyrrolate and Atropine as Adjuncts to Reversal of Non-Depolarizing Neuromuscular Blocking Agents on Postoperative Catheter-Related Bladder Discomfort

• Status: Unknown
• Phase: N/A
• Study type: Interventional
• Enrollment: 76 (estimated)
• Sponsor: Seoul National University Hospital · Academic / Other
• Sex: All
• Age: 19 Years – 80 Years
• Healthy volunteers: Not accepted

Summary

We want to evaluate the efficacy of the glycopyrrolate and atropine for the prevention of catheter-related bladder discomfort.

Detailed description

The mechanism of catheter-related bladder discomfort is thought to be related to the muscarinic receptor. The adjuncts to reversal agents such as glycopyrrolate and atropine are known to block the muscarinic receptor in different ways. We want to evaluate the efficacy of the glycopyrrolate and atropine for the prevention of catheter-related bladder discomfort.

Conditions

• Catheter Site Discomfort
• Complications
• Anesthesia
• Urinary Bladder Neoplasms

Interventions

Type	Name	Description
DRUG	Glycopyrrolate	Glycopyrrolate will be administered.
DRUG	Atropine	Atropine will be administered.

Timeline

• Start date: 2014-09-01
• Primary completion: 2015-02-01
• Completion: 2015-03-01
• First posted: 2014-08-29
• Last updated: 2014-10-28

Locations

1 site across 1 country: South Korea